PD-1 antibody (AA 21-170) (Biotin)

Catalog No. ABIN7164684

The Rabbit Polyclonal anti-PD-1 antibody has been validated for ELISA. It is suitable to detect PD-1 in samples from Human.

Quick Overview for PD-1 antibody (AA 21-170) (Biotin) (ABIN7164684)

Target: PD-1 (PDCD1) (Programmed Cell Death 1 (PDCD1))

Reactivity: Human

Host: Rabbit

Clonality: Polyclonal

Conjugate: This PD-1 antibody is conjugated to Biotin

Application: ELISA

Product Details anti-PD-1 Antibody (Biotin)

Binding Specificity: AA 21-170

Cross-Reactivity: Human

Purification: >95%, Protein G purified

Immunogen: Recombinant Human Programmed cell death protein 1 protein (21-170AA)

Isotype: IgG

Application Details

Application Notes: Optimal working dilution should be determined by the investigator.

Restrictions: For Research Use only

Handling

Format: Liquid

Buffer: Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4

Preservative: ProClin

Precaution of Use: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Storage: -20 °C,-80 °C

Storage Comment: Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.

Target Details for PD-1

Target: PD-1 (PDCD1) (Programmed Cell Death 1 (PDCD1))

Alternative Name: PDCD1

Background:

Background: Inhibitory cell surface receptor involved in the regulation of T-cell function during immunity and tolerance. Upon ligand binding, inhibits T-cell effector functions in an antigen-specific manner. Possible cell death inducer, in association with other factors.

Aliases: CD279 antibody, CD279 antigen antibody, hPD 1 antibody, hPD l antibody, hPD-1 antibody, hSLE1 antibody, PD 1 antibody, PD-1 antibody, PD1 antibody, PDCD 1 antibody, PDCD1 antibody, PDCD1_HUMAN antibody, Programmed cell death 1 antibody, Programmed cell death 1 protein antibody, Programmed cell death protein 1 antibody, Protein PD 1 antibody, Protein PD-1 antibody, SLEB2 antibody, Systemic lupus erythematosus susceptibility 2 antibody

UniProt: Q15116

Pathways: Cancer Immune Checkpoints